Refine by
Diabetes Testing And Monitoring Articles & Analysis: Older
6 news found
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced the appointment of Sahil Nock as the Company's Chief Commercial Officer, effective February 28, 2022. Mr. Nock brings to Creative ...
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan. The innovative device, which is the size of a £2 coin and worn on the arm, means people with Type 1 do not have to carry out multiple painful finger-prick checks to monitor their blood sugar levels. Instead, people with the condition can monitor their ...
This year's cohort includes a diverse pool of companies that focus on every topic from diabetes monitoring to substance use treatment and workflow tools to senior ride sharing. ...
The company has developed three patented innovative point-of-care products; beyond proof of concept, ready to be manufactured and deployed in the market. The Epinex G1A test for glycated albumin will be used for diabetes monitoring, screening, and diagnostics. It addresses the gap between daily blood sugar testing and HbA1c ...
The diabetes risk test evaluates the user’s likelihood to develop diabetes. ...
Moreover, with specific reimbursement codes already in place, insurance providers are likely to offer coverage for the test. The test could thus save billions of dollars in healthcare expenditures and cause a paradigm shift in the way diabetes is screened, diagnosed and monitored. Additionally, monthly glycation ...